| Year | Title | Author(s) |
| 2024 |
ERG and c-MYC regulate a critical gene network in BCR::ABL1-driven B cell acute lymphoblastic leukemia
Science Advances |
Behrens, K Brajanovski, N Xu, Z Viney, EM Dirago, L Hediyeh-Zadeh, S Davis, MJ Pearson, RB Sanij, E Alexander, WS Ng, AP |
| 2024 |
Targeting the ribosome to treat multiple myeloma
Molecular Therapy Oncology |
Maclachlan, KH Gitareja, K Kang, J Cuddihy, A Cao, YX Hein, N Cullinane, C Ang, CS Brajanovski, N Pearson, RB Khot, A Sanij, E Hannan, RD Poortinga, G Harrison, SJ |
| 2021 |
Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy
Signal Transduction And Targeted Therapy |
Kang, J Brajanovski, N Chan, KT Xuan, JC Pearson, RB Sanij, E |
| 2021 |
Harnessing the Nucleolar DNA Damage Response in Cancer Therapy
Genes |
Xuan, JC Gitareja, K Brajanovski, N Sanij, E |
| 2020 |
CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer
Nature Communications |
Sanij, E Hannan, KM Xuan, JC Yan, SF Ahern, JE Trigos, AS Brajanovski, N Son, J Chan, KT Kondrashova, O Lieschke, E Wakefield, MJ Frank, D Ellis, S Cullinane, C Kang, J Poortinga, G Nag, P Deans, AJ Khanna, KK Mileshkin, L McArthur, GA Soong, J Berns, EMJJ Hannan, RD Scott, CL Sheppard, KE Pearson, RB |